Current Options in the Prevention of Thromboembolic Disease
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 64  (1) , 1-5
- https://doi.org/10.2165/00003495-200464001-00002
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Risk Factors for Venous ThromboembolismCirculation, 2003
- BivalirudinDrugs, 2002
- ArgatrobanDrugs, 2001
- DesirudinDrugs, 2000
- Management of Deep Vein Thrombosis and Pulmonary EmbolismCirculation, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- HeparinNew England Journal of Medicine, 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- A 30-year survey of pulmonary embolism verified at autopsy: An analysis of 1274 surgical patientsBritish Journal of Surgery, 1985
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976